GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulmonx Corp (STU:4NI) » Definitions » Float Percentage Of Total Shares Outstanding

Pulmonx (STU:4NI) Float Percentage Of Total Shares Outstanding : 70.39% (As of Sep. 22, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Pulmonx Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Pulmonx's float shares is 27.56 Mil. Pulmonx's total shares outstanding is 39.15 Mil. Pulmonx's float percentage of total shares outstanding is 70.39%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Pulmonx's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Pulmonx's Institutional Ownership is 59.85%.

Pulmonx Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Pulmonx's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=27.56/39.15
=70.39%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pulmonx Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulmonx Corp (STU:4NI) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
SILK NNOX CVRX TCMD SENS ARAY RCEL CERS BVS ALUR ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
LUNG:USA
Address
700 Chesapeake Drive, Redwood, CA, USA, 94063
Website
https://www.pulmonx.com
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the U.S. and international markets.

Pulmonx Headlines

No Headlines